Anavex Life Sciences Corp. financial data

Symbol
AVXL on Nasdaq
Location
630 5 Th Avenue, 20 Th Floor, New York, NY
Fiscal year end
September 30
Former names
Thrifty Printing Inc. (to 1/25/2007)
Latest financial report
10-Q - Q4 2024 - Feb 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 10 % +14%
Return On Equity -37.5 % -23.7%
Return On Assets -34.1 % -22.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 84.8M shares +3.33%
Common Stock, Shares, Outstanding 85M shares +3.53%
Entity Public Float 412M USD -38.2%
Common Stock, Value, Issued 85K USD +3.66%
Weighted Average Number of Shares Outstanding, Basic 84.8M shares +3.32%
Weighted Average Number of Shares Outstanding, Diluted 84.8M shares +3.32%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 43.6M USD +8.1%
General and Administrative Expense 11.5M USD +0.66%
Operating Income (Loss) -55.1M USD -6.46%
Nonoperating Income (Expense) 8.6M USD -0.26%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -43M USD +9.47%
Net Income (Loss) Attributable to Parent -46.5M USD -7.73%
Earnings Per Share, Basic -0.55 USD/shares -1.85%
Earnings Per Share, Diluted -0.55 USD/shares -1.85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 121M USD -16%
Assets 124M USD -16.2%
Accounts Payable, Current 4.57M USD +6.41%
Accrued Liabilities, Current 7.73M USD +6.12%
Liabilities 13.1M USD +5.07%
Retained Earnings (Accumulated Deficit) -348M USD -15.4%
Stockholders' Equity Attributable to Parent 111M USD -18.2%
Liabilities and Equity 124M USD -16.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.1M USD -65.6%
Net Cash Provided by (Used in) Financing Activities 708K USD +1100%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 85M shares +3.53%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 121M USD -16%
Deferred Tax Assets, Valuation Allowance 92.2M USD +19.5%
Deferred Tax Assets, Gross 15.1M USD +110%
Deferred Tax Assets, Operating Loss Carryforwards 48.1M USD +3.6%
Current Income Tax Expense (Benefit) 59K USD -79%
Preferred Stock, Shares Authorized 10M shares 0%
Share-based Payment Arrangement, Expense 9.2M USD -31.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%